Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lipocine Inc.

NASDAQ: LPCN · Life Sciences · 10 alerts · CIK 1535955

Share price
$1.66Close, Nov 16
Market cap
$18.4M
Shares outstanding
11.07MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lipocine Inc. filings on SEC EDGAR ↗

3:24 PM ET Form 4
Insider Buying

Lipocine CEO Mahesh V. Patel Buys $79.5K of Stock

Mahesh V. Patel, CEO, bought 50,000 shares of Lipocine Inc. at $1.58 to $1.60 a share (average $1.59) in 2 transactions, worth $79.5K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 211,495 (+13.4%).

Value
$79.5K
Shares
50,000
Average price
$1.59
Role
CEO
Holding change
+13.4%
Trade date
Nov 12, 2026 to Nov 13, 2026
8:28 PM ET Form 4
Insider Buying

Lipocine Insider John W. Higuchi Buys $55K of Stock

John W. Higuchi bought 25,007 shares of Lipocine Inc. at $2.15 to $2.23 a share (average $2.20) in 2 transactions, worth $55K in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 241,365 (+7.1%).

Value
$55K
Shares
25,007
Average price
$2.20
Holding change
+7.1%
Trade date
Sep 29, 2026 to Sep 30, 2026
8:38 PM ET Form 4
Insider Buying

Lipocine Insider John W. Higuchi Buys $27.1K of Stock

John W. Higuchi bought 12,561 shares of Lipocine Inc. at $2.16 a share, worth $27.1K in total on Sep 28, 2026. Shares held after the trade: 216,358 (+6.2%).

Value
$27.1K
Shares
12,561
Price
$2.16
Holding change
+6.2%
Trade date
Sep 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.